General Medicine Group Limited
Temporary employment agency activities · London
ActiveUnited KingdomIncorporated 2009Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£1,177,000
Cash
—
Turnover
£30,000
Profit / loss
£6,000
Current assets
£6,535,000
Creditors < 1 year
£5,358,000
Equity
£1,177,000
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read | 2009-09-30 |
|---|---|---|---|
| Balance sheet | |||
| Net assets | £1,177,000 | £1,171,000 | £1 |
| Equity | £1,177,000 | £1,171,000 | £1 |
| Retained earnings | £1,177,000 | £1,171,000 | — |
| Assets | |||
| Current assets | £6,535,000 | £6,691,000 | — |
| Cash at bank | — | — | £1 |
| Debtors | £6,535,000 | £6,685,000 | — |
| Liabilities | |||
| Creditors | £5,358,000 | £5,520,000 | — |
| Creditors within one year | £5,358,000 | £5,520,000 | — |
| Net current assets | £1,177,000 | £1,171,000 | — |
| Assets less current liabilities | £1,177,000 | £1,171,000 | — |
| Profit & loss | |||
| Turnover | £30,000 | £2,609,000 | — |
| Cost of sales | £24,000 | £2,371,000 | — |
| Gross profit | £54,000 | £238,000 | — |
| Operating profit | £6,000 | £32,000 | — |
| Profit before tax | £6,000 | £32,000 | — |
| Profit / loss | £6,000 | £32,000 | — |
| Source evidence | View filing | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Audit
- Subsidiary audit exemption, parent guarantee (s479A)
- Immediate parent
- Pathology Group Limited
- Ultimate parent
- Acacium Group Limited
- Ultimate controlling party
- Onex Corporation
- Accounts
- Small company
- Approved
- 2026-07-31, signed by T C Richards
Borrowings (6)
- £375m senior loan facility · £375m · maturity date of 8 June 2028
- incremental facility · $140m · maturity date of 8 June 2028
- £45m revolving credit facility (“RCF”) · £45m · maturity date of 8 December 2027
- $10m line of credit in the US (“LoC”) · $10m · maturity date of 13 August 2026; extended annually
- £20m non-recourse financing facility · £20m
- £15m recourse facility · £15m · matures in March 2027
Share classes (1)
- 1 Ordinary of £1
Events after the year end (1)
- There were no post balance sheet events.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesAll Assets · created 2021-09-03
—
OutstandingShow 4 satisfied / released
All Assets · created 2019-03-06 · satisfied 2021-06-09
—
SatisfiedAll Assets · created 2014-08-22 · satisfied 2019-03-06
—
SatisfiedFixed · created 2013-12-23 · satisfied 2014-08-28
—
SatisfiedAll Assets · created 2011-06-30 · satisfied 2013-11-02
All monies
Satisfied